|
Official Journal |
EN L series |
|
2024/1575 |
4.7.2024 |
DECISION OF THE EEA JOINT COMMITTEE No 64/2024
of 15 March 2024
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1575]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (1), as corrected by OJ L 101, 14.4.2023, p. 101, is to be incorporated into the EEA Agreement. |
|
(2) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
|
1. |
The following indent is added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
|
|
2. |
The following point is inserted after point 13zzzzzzzzzzzzzw (Commission Implementing Regulation (EU) 2023/1488):
|
Article 2
The text of Implementing Regulation (EU) 2023/741, as corrected by OJ L 101, 14.4.2023, p. 101, in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 16 March 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 15 March 2024.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/1575/oj
ISSN 1977-0677 (electronic edition)